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Systemic Candida albicans infection causes high morbidity and mortality and is associated with neutropenia; 
however, the roles of other innate immune cells in pathogenesis are poorly defined. Here, using a mouse model 
of systemic candidiasis, we found that resident macrophages accumulated in the kidney, the main target organ 
of infection, and formed direct contacts with the fungus in vivo mainly within the first few hours after infec-
tion. Macrophage accumulation and contact with Candida were both markedly reduced in mice lacking chemo-
kine receptor CX3CR1, which was found almost exclusively on resident macrophages in uninfected kidneys. 
Infected Cx3cr1–/– mice uniformly succumbed to Candida-induced renal failure, but exhibited clearance of the 
fungus in all other organs tested. Renal macrophage deficiency in infected Cx3cr1–/– mice was due to reduced 
macrophage survival, not impaired proliferation, trafficking, or differentiation. In humans, the dysfunctional 
CX3CR1 allele CX3CR1-M280 was associated with increased risk of systemic candidiasis. Together, these data 
indicate that CX3CR1-mediated renal resident macrophage survival is a critical innate mechanism of early 
fungal control that influences host survival in systemic candidiasis.
Introduction
Systemic candidiasis is the fourth leading cause of nosocomial 
bloodstream infection in intensive care units (1, 2). Its incidence 
has dramatically risen over the past decades to more than 20 
cases/100,000 population, with an annual cost of approximately 
2 billion dollars in the US (1–4). Vaccines are not available, 
and despite antifungal therapy, mortality of infected patients 
exceeds 30%–40% (1, 2). Strikingly, the risk of systemic candi-
diasis and its clinical outcome vary significantly even among 
patients with similar predisposing clinical and microbiological 
factors (1, 2), indicating that important host-related risk factors 
remain to be discovered.
A model of systemic candidiasis has been established in which 
mice develop renal failure and septic shock (5), similar to infect-
ed humans (6–8), and in which the kidney is the primary target 
organ (5, 9). Neutrophils are critical in anti-Candida host defense 
in this model (10–12), consistent with predisposition to systemic 
candidiasis in patients with innate immune defects (13), particu-
larly neutropenia (2). Much less is known about the role in patho-
genesis of mononuclear phagocytes, which also accumulate in 
Candida-infected tissues (9, 14) and can directly kill Candida (15). 
Thus, monocytes/macrophages may contribute to fungal control, 
but the mechanisms of trafficking, activation, and effector func-
tion remain unclear. To interrogate the roles of monocytes/macro-
phages in systemic candidiasis, we focused on CCR2 and CX3CR1, 
the “signature” chemokine receptors for inflammatory and resi-
dent monocyte/macrophages, respectively (16, 17). Importantly, 
we found that CX3CR1+ resident macrophages play a critical role 
for survival and control of fungal proliferation in the mouse 
model of systemic candidiasis and show that genetic variation at 
CX3CR1 is a risk factor for the infection in humans.
Results
Cx3cr1 is critical for survival in a mouse model of systemic candidiasis. 
To identify monocyte/macrophage-targeted molecular factors 
that may be important in anti-Candida host defense, we exam-
ined the expression of Ccr2 and Cx3cr1 and their ligands Ccl2/
Mcp-1 and Cx3cl1/fractalkine, respectively, in WT Candida-infected 
kidneys. mRNA for Ccr2 and Cx3cr1 and their ligands was sig-
nificantly and durably induced after infection (Figure 1, A and 
B). We then assessed receptor expression on kidney monocytes/
macrophages. Monocytes were defined as MHCII–F4/80intCD11c–
CD11b+ leukocytes with typical monocyte morphology by trans-
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Figure 1
Systemic candidiasis induces the expression of Ccr2, Cx3cr1, 
and their ligands. (A) Ccr2 and Cx3cr1 are induced in the kidney 
of Candida-infected Cx3cr1+/+ mice (n = 8–10; 2 independent 
experiments). P < 0.0001 for Ccr2 and Cx3cr1 expression on days 
3, 6, and 9 versus day 0. (B) Ccl2 and Cx3cl1 are induced in the 
kidney of Candida-infected Cx3cr1+/+ mice (n = 8–10; 2 indepen-
dent experiments). P < 0.0001 for Ccl2 and Cx3cl1 expression 
on days 3, 6, and 9 versus day 0. (C) Phenotypic characterization 
of monocytes, macrophages, and dendritic cells in the kidney in 
the mouse model of systemic candidiasis. Representative FACS 
analysis shows the gating strategy used to define MHCII–F4/80int 
monocytes, MHCIIhiF4/80hi macrophages, and MHCIIhiF4/80lo 
dendritic cells after pregating on live CD45+CD3–CD19–NK1.1–
Ly6G– cells. Also shown are representative TEM of the 3 popula-
tions FACS sorted at day 6 after infection. Scale bars: 2 μm. (D) 
Representative FACS histograms of Ccr2 and Cx3cr1 staining on 
kidney Ly6Chi and Ly6Clo monocytes and macrophages at day 6 
after infection (n = 6; 2 independent experiments).
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mission electron microscopy (TEM) and could be divided into 
Ly6Chi and Ly6Clo subpopulations. Macrophages were defined as 
MHCIIhiF4/80hiCD11cloCD11b+ leukocytes and exhibited clas-
sic macrophage morphological features such as eccentric nuclei, 
abundant cytoplasm, and numerous phagocytic vacuoles and 
lysosomal granules by TEM (Figure 1C). Ccr2 was expressed on all 
Ly6Chi monocytes, approximately 50%–70% of Ly6Clo monocytes, 
and approximately 70%–80% of macrophages, whereas Cx3cr1 was 
expressed at high levels on Ly6Clo monocytes and macrophages 
and intermediate levels on Ly6Chi monocytes (Figure 1D).
Mortality of Ccr2–/– mice following systemic candidiasis was 
only slightly increased compared with Ccr2+/+ mice (Figure 2A). 
In contrast, using an LD50 inoculum defined in Cx3cr1+/+ control 
mice, Candida infection was uniformly fatal in Cx3cr1–/– mice (Fig-
ure 2A). This phenotype was reproduced using 2 independent 
Cx3cr1-deficient mouse lines, 3 different Candida inocula, and 3 
different Candida strains (Figure 2A and data not shown), and 
therefore is robust. Cx3cr1 deficiency caused a more pronounced 
weight loss (Figure 2B) and resulted in significantly higher kidney 
fungal burden throughout the course of the infection (Figure 2C). 
Moreover, while Candida was mostly contained within abscesses 
in Cx3cr1+/+ kidneys, pseudohyphae inexorably invaded the renal 
pelvis and frequently formed large fungal balls in Cx3cr1–/– mice 
(Figure 2, D and E). Cx3cr1–/– mice also exhibited greater fungal 
burden in the brain and liver but not in the spleen; however, Can-
dida was eventually controlled in these organs (Supplemental Fig-
ure 1A; supplemental material available online with this article; 
doi:10.1172/JCI71307DS1).
Cx3cr1–/– kidneys appeared paler and more swollen than WT kid-
neys by gross pathology (Figure 2F). Accordingly, infected Cx3cr1–/– 
mice developed severe kidney failure after infection (Figure 2G) asso-
ciated with more extensive inflammatory changes, tubular casts, and 
papillary necrosis (Figure 2, D and H) and greater induction of pro-
inflammatory cytokines than in kidneys of infected WT mice (Fig-
ure 2I). In contrast, Cx3cr1 deficiency did not affect the histology 
of brain, liver, or spleen of infected mice (Supplemental Figure 1B). 
Thus, for the remainder of our studies, we focused on the effects of 
Cx3cr1 in the kidney.
Cx3cr1 on hematopoietic and nonhematopoietic cells confers protection 
against systemic candidiasis. Because Cx3cr1 is expressed on both 
hematopoietic and nonhematopoietic cells (16–20), we asked 
whether increased susceptibility of Cx3cr1–/– mice to systemic 
candidiasis was due to Cx3cr1 deficiency in the hematopoietic or 
nonhematopoietic compartment, or both. Therefore, we gener-
ated BM chimeras and infected them with Candida 10 weeks after 
successful reconstitution (Supplemental Figure 2). Both Cx3cr1+/+ 
mice reconstituted with Cx3cr1–/– BM and Cx3cr1–/– mice reconsti-
tuted with Cx3cr1+/+ BM were susceptible to systemic candidiasis 
and recapitulated the phenotype observed in Cx3cr1–/– mice and 
Cx3cr1–/–→Cx3cr1–/– chimeras (Figure 3A), suggesting that Cx3cr1 
within both hematopoietic and nonhematopoietic compartments 
is required for protection.
To better understand the biological function of Cx3cr1, we next 
examined Cx3cr1 expression on kidney hematopoietic and non-
hematopoietic cells using Cx3cr1gfp/+ mice, which are significantly 
protected from infection compared with Cx3cr1gfp/gfp mice but 
slightly more susceptible than WT mice (Figure 2A). We did not 
detect Cx3cr1 on endothelial or epithelial cells by FACS (data not 
shown) or confocal microscopy (Figure 3B). Within the hemato-
poietic compartment, Cx3cr1 was expressed on monocytes/macro-
phages (Figure 1D) but not neutrophils (Figure 3C), the 2 predom-
inant leukocyte subsets in the kidney (Supplemental Table 1), and 
on a subset of T cells (∼25%), NK cells (∼20%), and dendritic cells 
(CD11b+CD103– greater than CD103+CD11b–), but not on B cells 
(Figure 3C and data not shown). Because the monocyte/macro-
phage is the major Cx3cr1+ cell type in the model and because 
clodronate administration, which depletes monocytes/macro-
phages, has been reported to increase mortality in the model (11), 
we focused our analysis of mechanisms on the effects of Cx3cr1 on 
mononuclear phagocyte distribution and function in the kidney.
Mononuclear phagocytes interact with Candida early after infection 
in a Cx3cr1-dependent manner. We first aimed to characterize the 
distribution of mononuclear phagocytes and their topographic 
association with fractalkine and Candida in the kidney. Using 
Cx3cr1gfp/+ mice, we found that mononuclear phagocytes formed 
a network in the uninfected kidney and accumulated throughout 
the renal parenchyma surrounding glomeruli and renal tubules 
after infection (Figure 3B). Fractalkine was detected in glomeru-
lar endothelial cells and in tubular cells (Figure 3D), confirming 
previous reports (21). Kidney macrophages also expressed frac-
talkine (Figure 3E), which may act in an autocrine manner on 
the cells (18, 22).
We then employed confocal microscopy to visualize the inter-
action of kidney mononuclear phagocytes with the fungus. Kid-
neys were harvested from Cx3cr1gfp/+ mice infected with dToma-
to-expressing Candida and imaged immediately. Candida rapidly 
invaded the kidney and formed 20-μm–long filaments as early as 
2 hours after intravenous injection (Figure 4A). At this time point, 
the majority of Candida yeast and pseudohyphal elements were 
in contact with mononuclear phagocytes, internalized within or 
encased by them (Figure 4A), respectively. By day 1 after infection, 
mononuclear phagocytes were no longer in direct contact with 
Candida; instead, pseudohyphae were only occasionally surround-
ed by mononuclear phagocytes in the renal interstitium, and more 
than 90% of pseudohyphal structures had already extended within 
renal tubules (Figure 4A and Supplemental Figure 3). Conversely, 
mononuclear phagocytes surrounded the tubules and were not 
detected within the renal collecting system at any time-point ana-
lyzed (Figure 3B and Figure 4A).
After characterizing the interaction of kidney mononuclear 
phagocytes with Candida in Cx3cr1gfp/+ mice, we asked whether 
Cx3cr1 deficiency impedes the ability of mononuclear phago-
cytes to contact Candida early after infection. Strikingly, while 
approximately 90% of Candida elements were either internal-
ized or encircled by Cx3cr1gfp/+ mononuclear phagocytes, only 
approximately 60% of Candida elements were in contact with 
Cx3cr1gfp/gfp mononuclear phagocytes in the kidney 2 hours after 
infection (Figure 4B). Hence, our data demonstrate that mono-
nuclear phagocytes interact with Candida almost exclusively very 
early after infection and this interaction is dependent on func-
tional Cx3cr1. Because resident macrophages are by far the most 
abundant Cx3cr1+ mononuclear phagocytes compared with resi-
dent monocytes and dendritic cells in the kidney at this very 
early phase of the infection (∼80%–85%; Supplemental Table 1), 
we next focused on the function of macrophages in the model.
Cx3cr1 deficiency results in significantly decreased macrophage accumu-
lation in the kidney both at steady state and throughout infection. To gain 
insight into the Cx3cr1-dependent interaction of macrophages 
with Candida, we first investigated whether Cx3cr1 deficiency 
adversely affects Candida recognition, as Cx3cr1 has adhesion 
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Figure 2
Systemic candidiasis is uniformly fatal in Cx3cr1–/– mice due to uncontrolled fungal proliferation in the kidney and renal failure. (A) Mortality. 
Data represent summary results from Ccr2+/+ and Ccr2–/– mice (left; n = 15; 2 independent experiments), Cx3cr1+/+ and Cx3cr1–/– mice (middle; 
n = 33–35; 3 independent experiments), and Cx3cr1+/+, Cx3cr1gfp/+ and Cx3cr1gfp/gfp mice (right; n = 25–29; 2 independent experiments; P < 0.0001 
for Cx3cr1+/+ versus Cx3cr1gfp/gfp, P < 0.0001 for Cx3cr1gfp/+ versus Cx3cr1gfp/gfp mice; P = 0.09 for Cx3cr1+/+ versus Cx3cr1gfp/+ mice). (B) Weight 
loss. *P < 0.01 (n = 23–24; 2 independent experiments). (C) Fungal burden in the kidney. *P = 0.02; **P < 0.001 (n = 19–23; 3 independent experi-
ments). (D) PAS staining. Cross-sections of Cx3cr1+/+ and Cx3cr1–/– kidneys on day 6 after Candida infection (n = 8; 3 independent experiments). 
Original magnification, ×200. (E) Candida fungal balls in the Cx3cr1gfp/gfp renal pelvis. Confocal images of Cx3cr1gfp/+ and Cx3cr1gfp/gfp kidney 
at day 6 after infection with dTomato-expressing Candida (n = 3; 2 independent experiments). Scale bars: 200 μm. Objective, ×2. (F) Anatomic 
pathology of infected kidneys. Representative kidneys are shown for 2 mice of each genotype sacrificed at day 9 after infection. (G) Renal function. 
*P < 0.001 (n = 8–10; 2 independent experiments). (H) Histopathology. Representative H&E staining of kidney sections at day 9 after infection. 
Original magnification, ×20 (top row); ×100 (bottom row) (n = 8; 3 independent experiments). (I) Proinflammatory cytokine induction at day 9 after 
infection. *P = 0.03. **P < 0.01 (n = 8–10, day 9 after infection; 2 independent experiments). All quantitative data represent mean ± SEM.
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properties (23). Cx3cr1+/+ and Cx3cr1–/– BM-derived macrophages 
(BMMs) had similar capacities for Candida (Figure 4C) or zymo-
san binding (data not shown), and Candida internalization (Figure 
4D). Cx3cr1 deficiency also did not alter dectin-1 or TLR2 expres-
sion on macrophages (data not shown).
Based on these findings, we hypothesized that Cx3cr1 defi-
ciency impairs in vivo kidney macrophage:Candida interaction 
by influencing macrophage accumulation in that organ. Indeed, 
Cx3cr1 deficiency was associated with approximately 50% reduc-
tion in the number of macrophages in Cx3cr1–/– kidneys and 
decreased macrophage density in Cx3cr1gfp/gfp kidneys at steady 
state (Figure 4E). Furthermore, Cx3cr1–/– kidneys accumulated 
approximately 50% fewer macrophages than Cx3cr1+/+ kidneys 
throughout the entire course of the infection (Figure 4F). In 
contrast, more neutrophils accumulated (Figure 5, A and B, and 
Supplemental Figure 4) and induction of neutrophil-targeted 
chemoattractants was greater in Cx3cr1–/– infected kidneys 
(Figure 5, C–F).
Cx3cr1 mediates macrophage survival and inhibits caspase-dependent 
apoptosis associated with Akt activation. We next aimed to investigate 
the mechanism(s) underlying the decreased macrophage accu-
mulation in Cx3cr1–/– kidneys, which could be explained by the 
net effect of decreased (a) in situ macrophage proliferation, and/
or (b) monocyte trafficking into the kidney, and/or (c) monocyte 
Figure 3
Cx3cr1-expressing kidney mononuclear phagocytes engulf Candida early after infection in a mouse model of systemic candidiasis. (A) Cx3cr1 on 
both hematopoietic and nonhematopoietic cells is critical for survival in systemic candidiasis. Upper right identifies the 4 groups of BM chimeras 
(donor→recipient). P < 0.001 for WT→WT versus each of the other 3 groups (n = 15–25/group). Data are shown from 1 of 2 independent experi-
ments with similar pattern of results. (B) Cx3cr1-expressing mononuclear phagocytes are present constitutively in uninfected kidney (left; renal 
cortex) and accumulate after Candida infection (middle, day 6 after infection; corticomedullary junction), surrounding but not invading the renal 
collecting system (right, day 6 after infection; corticomedullary junction). Images are representative confocal micrographs from Cx3cr1gfp/+ kidneys 
(n = 3–4; 2 independent experiments). Scale bars: 200 μm (left); 150 μm (middle); 20 μm (right). Objective, ×10 (left and middle), ×60 (right). (C) 
Representative FACS histogram of Cx3cr1 staining on kidney neutrophils and dendritic cells at day 6 after infection (n = 6; 2 independent experi-
ments). (D) Cx3cl1 is expressed in glomeruli (left) and tubular cells (middle), predominantly at the corticomedullary junction. Images were gener-
ated by Cx3cl1 IHC staining of Cx3cr1+/+ kidneys obtained 6 days after infection. Isotype control staining is also seen (right) (n = 6; 2 independent 
experiments). Original magnification, ×600. (E) Relative mRNA expression of Cx3cl1 in macrophages (day 0 and 6 after infection), endothelial cells 
(day 0), and tubular cells (day 0) FACS-sorted from Cx3cr1+/+ kidneys (n = 4–6; 2 to 3 independent experiments). Data represent mean ± SEM.
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Figure 4
Cx3cr1 deficiency results in decreased steady state and Candida-induced accumulation of kidney macrophages as well as reduced 
interaction of kidney mononuclear phagocytes with Candida. (A) Cx3cr1-expressing mononuclear phagocytes directly interact with 
C. albicans only early in infected mouse kidney. Images depict 3 different types of interaction, as indicated by the labels, in the kidneys 
of Cx3cr1gfp/+ mice 2 hours (left and middle) and 1 day (right) after infection (n = 3; 3 independent experiments). Scale bars: 5 μm (left, 
middle); 20 μm (right). Objective, ×60. (B) Decreased frequency of dTomato-Candida in contact with GFP-marked mononuclear phago-
cytes in the kidney in the absence of Cx3cr1. Left, data are summarized from 3 experiments 2 hours after Candida challenge. *P = 0.002. 
Right, representative confocal images. Scale bars: 5 μm. Objective, ×60. (C) Cx3cr1 deficiency does not affect binding of EGFP-Candida 
by BMMs in vitro (n = 9; 3 independent experiments). (D) Cx3cr1 deficiency does not affect phagocytosis of EGFP-Candida by BMMs in 
vitro (n = 12; 4 independent experiments). (E) Total macrophages in uninfected mouse kidney. Left, summary data obtained by FACS for 
MHCIIhiF4/80hiCD11b+ cells isolated from kidneys from the indicated mouse strains. *P < 0.001 (n = 9; 3 independent experiments). Right, 
representative confocal images from the indicated mouse strains (n = 4; 2 independent experiments). Scale bars: 50 μm. Objective, ×10. 
(F) Number of macrophages extracted from mouse kidney over time after Candida infection. *P = 0.02; **P < 0.01; ***P < 0.001 (n = 9–15/
time-point; 3 to 4 independent experiments).
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differentiation into macrophages within the kidney, and/or (d) 
macrophage survival in the kidney. Cx3cr1 has been shown to 
mediate cell proliferation (22, 24); however, the percentage of 
proliferating macrophages, measured by Ki-67 positivity using 
FACS, was similar in Cx3cr1+/+ and Cx3cr1–/– kidneys at steady 
state and throughout infection (Figure 6A). Also, levels of IL-4, 
which may drive local macrophage proliferation in vivo (25), were 
not decreased in infected Cx3cr1–/– kidneys (data not shown).
To test the role of Cx3cr1 on monocyte trafficking and differen-
tiation directly, we transferred sorted GFP+CD115+Ly6ChiCD11b+ 
monocytes from uninfected Cx3cr1gfp/+ and Cx3cr1gfp/gfp BM into WT 
mice 3 days after infection. Cx3cr1 did not affect monocyte traf-
ficking, as similar numbers of Cx3cr1gfp/+ and Cx3cr1gfp/gfp cells were 
recruited into the kidney 12 hours after transfer (Figure 6B). Con-
sistent with the dispensable role of Cx3cr1 on monocyte traffick-
ing, monocyte accumulation was similar in Cx3cr1+/+ and Cx3cr1–/– 
kidneys (Figure 6C). Moreover, Cx3cr1 did not affect macrophage 
differentiation, as the percentage of Cx3cr1gfp/+ and Cx3cr1gfp/gfp cells 
that were MHCIIhiF4/80+CD11b+ was similar 3 days after monocyte 
transfer (Figure 6D).
While monocyte trafficking and differentiation were Cx3cr1 
independent, considerably fewer Cx3cr1gfp/gfp than Cx3cr1gfp/+ mac-
rophages persisted in the kidney 3 days after monocyte transfer 
(Figure 6E), suggesting a survival defect. Indeed, Cx3cr1+/+ kidneys 
had a higher proportion of annexin V–7-AAD– viable macrophages 
compared with Cx3cr1–/– kidneys at steady state and throughout 
infection (Figure 6, F and G). Correspondingly, the proportion of 
annexin V+7-AAD+ dead and annexin V+7-AAD– apoptotic macro-
phages was higher in Cx3cr1–/– than Cx3cr1+/+ kidneys before and 
after infection (Figure 6, F and G). Conversely, kidney neutrophils, 
which are Cx3cr1 negative (Figure 3C), had similar viability in 
Cx3cr1+/+ and Cx3cr1–/– mice (data not shown).
Consistent with a survival defect, higher amounts of cleaved cas-
pase-3 were detected in Cx3cr1-deficient macrophages sorted from 
infected kidneys (Figure 6H). The fractalkine-Cx3cr1 axis has been 
reported to mediate survival of rat microglia and rat and human 
smooth muscle cells via different mechanisms, which all involve 
PI3K-dependent Akt activation (22, 24, 26, 27). In agreement, Akt 
phosphorylation was reduced in sorted Cx3cr1–/– kidney macro-
phages (Figure 6H). Similarly, decreased expression of cleaved cas-
pase-3 and increased Akt phosphorylation were detected by FACS 
in Cx3cr1+/+ compared with Cx3cr1–/– kidney-resident macrophages 
at steady state (Supplemental Figure 5). These data demonstrate 
that Cx3cr1 deficiency results in decreased macrophage survival in 
the kidney associated with increased caspase-dependent apoptosis.
Kidney-resident macrophages inactivate Candida. Although decreased 
kidney macrophage accumulation correlated with increased fun-
gal proliferation in the kidney and diminished mouse survival, it is 
unknown whether renal resident macrophages, which are the prin-
cipal cells that come in contact with the fungus early after infec-
Figure 5
Cx3cr1 deficiency is associated with increased accumulation of neutrophils in the kidney after Candida infection. (A) Number of neutrophils 
extracted from mouse kidney over time after Candida infection. *P < 0.01; **P < 0.001 (n = 9–15; 3 to 4 independent experiments). (B) Neutrophil/
macrophage ratio in the kidney after Candida infection (n = 9–15; 3 to 4 independent experiments). (C–F) Kidney induction by Candida infection of 
the neutrophil-targeted chemokine receptor Cxcr2 and its ligands Cxcl1 and Cxcl2. RNA analysis, *P < 0.05; **P < 0.01 (n = 8–10; 2 independent 
experiments). Protein analysis, *P < 0.05 (n = 4; 1 independent experiment). All quantitative data represent mean ± SEM.
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tion, have direct anti-Candida activity. To address this question, 
we sorted kidney-resident macrophages from uninfected Cx3cr1+/+ 
mice and incubated them with Candida ex vivo at an effector/target 
cell ratio of 2:1. Using alamarBlue reduction as a measure of fun-
gal inactivation (28), we found that kidney-resident macrophages 
inactivated approximately 42% of fungal cells (Figure 7). We then 
asked whether Cx3cr1 deficiency impairs the ability of kidney-res-
ident macrophages to inactivate Candida. We found that Cx3cr1–/– 
kidney-resident macrophages exhibited a modest 12% decrease in 
Candida killing (i.e., ∼37%) compared with Cx3cr1+/+ cells (Figure 
7). These data show that renal-resident macrophages exert direct 
anti-Candida activity, which is slightly decreased in Cx3cr1–/– cells.
The decreased accumulation and effector function of kidney-resident 
macrophages in Cx3cr1-deficient mice is associated with uncontrolled 
fungal proliferation very early after infection. Because Cx3cr1+ kidney-
resident macrophages come in contact with Candida in vivo only 
within the first few hours after infection, and because Cx3cr1 defi-
ciency adversely affects the accumulation, survival, and fungicidal 
activity of these cells, we reasoned that the very early interactions 
of tissue-resident macrophages with Candida, when inflammatory 
monocytes and neutrophils are not yet recruited in the kidney, are 
critical for controlling the progression of the infection. In line with 
this, the fungal load in the kidneys of Cx3cr1–/– mice was signifi-
cantly increased as early as 12 hours after infection (Figure 8).
CX3CR1-M280 is associated with systemic candidiasis in humans. In 
humans, the CX3CR1-M280 SNP caused by a cytosine-to-thymidine 
substitution at nucleotide 839 that changes a threonine at posi-
tion 280 to methionine results in reduced fractalkine binding and 
impaired fractalkine-induced cell adhesion and chemotaxis (29). 
To test the hypothesis that this SNP may influence susceptibil-
ity to systemic candidiasis, we genotyped 281 candidemic patients 
and 384 noninfected controls from 2 patient cohorts from the US 
and the Netherlands (ref. 30 and Supplemental Tables 2 and 3).
The genotypes were in Hardy-Weinberg equilibrium in both 
groups. Comparison of frequencies of patients carrying the 
mutant CX3CR1-M280 allele versus the WT genotype among can-
didemic and control subjects in the combined groups yielded an 
odds ratio (OR) of 1.78 for patients of mixed European descent 
(Table 1; P = 0.0017; 95% CI, 1.24–2.55), but no difference for 
African-American subjects (Supplemental Table 4). In a multi-
variate model controlling for other clinical factors associated with 
systemic candidiasis, including solid organ transplantation, neu-
tropenia, receipt of total parenteral nutrition, and liver disease, 
the presence of the mutant CX3CR1-M280 allele was significantly 
associated with candidemia (Table 2; OR, 1.80; P = 0.0262, 95% CI, 
1.07–3.01). When intensive care unit admission status was added 
to the model, the association of CX3CR1-M280 with candidemia 
decreased slightly (OR, 1.60; P = 0.0685; 95% CI, 0.94–2.72).
While there was no association of CX3CR1-M280 with persistent 
fungemia or mortality (data not shown), candidemic patients of 
mixed European descent carrying the mutant allele were more 
likely to develop disseminated infection (30.1%) than those lack-
ing this allele (14%) (Table 3; P = 0.01; OR, 2.65; 95% CI, 1.22–5.74). 
This association remained significant in multivariate analysis 
when controlling for other clinical factors; in the final model, 
presence of the CX3CR1-M280 allele (OR, 2.83; P = 0.0104; 95% CI, 
1.30–6.45) and solid organ transplantation (OR, 3.65; P = 0.0045; 
95% CI, 1.48–8.99) were the only factors independently associated 
with development of disseminated candidiasis.
Discussion
In the present study we reveal a role of Cx3cr1-dependent tissue-
resident mononuclear phagocytes in host defense against systemic 
fungal infection and show that the dysfunctional CX3CR1-M280 
SNP is associated with susceptibility to human systemic candidia-
sis. The receptor appears to act directly by promoting macrophage 
survival and accumulation in tissue, which facilitates effective 
interaction between tissue-resident macrophages and Candida early 
after infection. Our conclusions are based on detailed analysis of 
differences in clinical, microbiological, pathological, immuno-
logical, imaging, biochemical and molecular parameters between 
WT and Cx3cr1-deficient mice. To the best of our knowledge, our 
study is the first to reveal the direct interaction of mononuclear 
phagocytes with the fungus at the site of infection and the first 
to identify a monocyte/macrophage-specific molecular factor that 
protects against systemic candidiasis in mice and humans.
Our results are consistent with a single report published in 
1994 that had not been followed up showing that clodronate-
induced monocyte/macrophage depletion in mice results in 
increased fungal burden and mortality after systemic candidia-
sis (11). No information was previously available on mechanisms 
by which monocytes/macrophages might promote antifungal 
protection or on whether anti-Candida host defense is mediated 
by resident monocytes/macrophages, recruited inflammatory 
monocytes/macrophages, or both. Our investigation of the roles 
of chemokine receptors CCR2 and CX3CR1 in anti-Candida host 
defense could elucidate this latter point because they are “signa-
ture” molecules for mouse and human inflammatory and resi-
dent monocytes/macrophages, respectively (16, 17). Specifically, 
Figure 6
Cx3cr1 deficiency increases apoptosis of kidney macrophages, but 
does not affect kidney macrophage differentiation or proliferation or 
monocyte trafficking from blood to kidney. (A) Kidney macrophage 
proliferation. Leukocytes were purified from kidneys of the indicated 
mouse lines, and endogenous MHCIIhiF4/80hiCD11b+ cells were ana-
lyzed for Ki67 expression (n = 6–10; 2 independent experiments). 
(B) Monocyte trafficking from blood to kidney after Candida infec-
tion. Adoptive transfer of BM-derived monocytes from the indicated 
uninfected mouse lines into WT mice 3 days after Candida infection. 
WT recipient mice were sacrificed 12 hours after cell transfer, and 
the number of GFP+ monocytes purified from kidneys was measured 
(n = 6–8; 2 independent experiments). (C) Endogenous monocyte 
accumulation in kidney after Candida infection (n = 9–15; 3 to 4 inde-
pendent experiments). (D) Macrophage differentiation. WT recipient 
mice were sacrificed 3 days after cell transfer, and the percentage of 
GFP+ cells from the indicated uninfected mouse lines that differentiated 
into MHCIIhiF4/80hiCD11b+ macrophages in kidneys was determined. 
(n = 6; 2 independent experiments). (E) Persistence of macrophages 
in the infected kidney 3 days after monocyte transfer is Cx3cr1 depen-
dent. Left, quantitation. *P = 0.001 (n = 6; 2 independent experi-
ments). Right, representative FACS plots. (F) Endogenous kidney 
macrophage survival before and after Candida infection. *P < 0.05; 
**P < 0.01; ***P < 0.001 (n = 6–8; 2 independent experiments). (G) 
Representative FACS plots for survival marker expression by kidney 
macrophages of uninfected mice quantified in F. (H) Cx3cr1 modu-
lates caspase-3 cleavage and Akt phosphorylation. Endogenous kid-
ney macrophages were sorted from Candida-infected kidneys 6 days 
after infection. Left, representative Western blot; middle and right, 
quantitation of Western blot data. β-actin is shown as loading control. 
*P = 0.03; **P < 0.01 (n = 4; 2 independent experiments). All quantita-
tive data represent mean ± SEM.
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mouse Ly6Chi inflammatory monocytes/macrophages correlate 
with human classical CD14++CD16– cells, which both express 
CCR2 and CX3CR1, whereas mouse Ly6Clo resident monocytes/
macrophages correlate with human nonclassical CD14+CD16+ 
cells, which both express CX3CR1, but not CCR2 (17). While 
the role of CCR2+ inflammatory monocytes/macrophages has 
been investigated in several infection models, the contribution 
of CX3CR1+ resident monocytes/macrophages in host defense 
remains less well defined (31).
Our study strongly supports a predominant role of resident mac-
rophages over recruited inflammatory monocytes/macrophages in 
anti-Candida innate host defense. First, Ccr2–/– mice, which are mono-
cytopenic and unable to mobilize inflammatory monocytes into tis-
sue after infection (31), did not display significantly enhanced sus-
ceptibility to systemic candidiasis. In contrast, Cx3cr1–/– mice were 
highly susceptible to infection despite the redundant role of Cx3cr1 
in monocyte accumulation in the kidney. Also, our confocal imag-
ing data provide evidence that Cx3cr1+ macrophages in the infected 
kidney interact with Candida within the first hours after infection, 
when only resident macrophages but not recruited inflammatory 
monocytes/macrophages are present in tissue.
Our study identifies Cx3cr1 as a protective molec-
ular factor in systemic candidiasis, which appears to 
operate by promoting macrophage accumulation in 
the kidney. The receptor has previously been shown 
to mediate macrophage accumulation in lamina 
propria, liver, and lung, but not spleen (32). The 
resultant approximately 50% decrease of tissue-resi-
dent macrophages in Cx3cr1–/– kidneys is associated 
with a significant reduction in Candida-macrophage 
contact in the kidney. Specifically, the percentage of 
Candida elements that are not in contact with kid-
ney tissue–resident macrophages is approximately 
4-fold greater in Cx3cr1–/– than Cx3cr1+/+ kidneys 
(∼40% versus ∼10%, respectively; Figure 4B) during 
the first 2 hours after infection. The ineffective mac-
rophage-Candida contact in Cx3cr1–/– kidneys early 
after infection, when inflammatory monocytes and 
neutrophils are not yet recruited, appears detrimental for arresting 
Candida proliferation, as fungal burden in Cx3cr1–/– kidneys is sig-
nificantly increased as early as 12 hours after infection (Figure 8). Of 
interest, while Cx3cr1 is important for control of Candida prolifera-
tion in kidney, liver, and brain, it is not in the spleen, the only organ 
among those examined in which resident macrophages are Cx3cr1-
negative (33) and do not depend on Cx3cr1 for tissue accumulation 
(32). Of note, although the capacity of kidney-resident macrophages 
to kill Candida was slightly decreased in Cx3cr1–/– cells, it appears 
that the effects of Cx3cr1 on macrophage accumulation predomi-
nate over the effects of the receptor on macrophage-killing activ-
ity in accounting for the large differences in kidney fungal burden 
and mouse survival between Cx3cr1+/+ and Cx3cr1–/– mice. Nonethe-
less, future studies will be required to determine the mechanism by 
which Cx3cr1 mediates macrophage candidacidal activity.
The mechanism of Cx3cr1-dependent macrophage accumula-
tion in the kidney does not relate to monocyte trafficking or differ-
entiation. This differs from the previously reported roles of Cx3cr1 
on monocyte recruitment into inflamed tissue during splenic lis-
teriosis and renal ischemia-reperfusion (34, 35) and on monocyte 
differentiation in liver fibrosis (36). Conversely, our data are con-
sistent with the redundant role of Cx3cr1 on monocyte trafficking 
and differentiation in the peritoneum (20). Instead, we show that 
Cx3cr1 mediates macrophage accumulation by providing surviv-
al signals both at steady state and throughout infection, which 
protect from apoptosis. These data reveal suggest a novel role for 
Cx3cr1-dependent macrophage survival in acute fungal control 
and are consistent with the reported Cx3cr1-dependent antiapop-
totic effects on macrophages in aorta and liver (36, 37). Additional 
work is required to define the molecular mechanisms that mediate 
Cx3cr1-dependent inhibition of macrophage caspase-dependent 
apoptosis downstream of Akt activation. Furthermore, future 
studies will be needed to determine which nonhematopoietic 
Cx3cr1+ cell or cells confer protection against systemic candidiasis 
and by which mechanism or mechanisms and to define the role 
of Cx3cr1+ renal resident dendritic cells in early innate immune 
responses against the fungus.
Two striking findings arise from our confocal studies. First, 
Candida promptly invades the kidney and forms 20- to 25-μm–
long filaments within just 2 hours after intravenous injection. 
Conversely, Candida filamentation, a key virulence factor (38), 
is not seen in liver or spleen (9). The rapidity of kidney-specif-
ic filamentation is remarkable in light of the requirement of 
Figure 7
Kidney-resident macrophages exhibit Candida-killing capacity, 
which is slightly decreased in Cx3cr1-deficient cells. Sorted Cx3cr1+/+ 
and Cx3cr1–/– kidney-resident macrophages inactivate 42% ver-
sus 37% of Candida yeast cells, respectively. *P = 0.028 (n = 6; 
3 independent experiments).
Figure 8
Cx3cr1 deficiency results in increased fungal proliferation in the kidney very early after 
Candida infection. (A) Shown are 12 hours (n = 18–19; 2 independent experiments) and 
(B) 24 hours after infection (n = 8–9; 2 independent experiments). *P < 0.001.
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approximately 2–3 hours for formation of approximately 5-μm 
germ-tubes in vitro using “filamentation-priming” conditions 
(39) and underscores the importance for future research aim-
ing to identify the kidney-specific factors that are permissive for 
accelerated filamentation.
Second, Candida is almost exclusively found within renal tubules 
by 24 hours after infection, where it penetrates from the renal 
interstitium. The universal invasion of Candida into renal tubules 
by day 1 after infection appears to act as an immune-evading 
mechanism because (a) monocytes/macrophages do not enter 
into the renal collecting system,and (b) neutrophils, which are 
recruited into renal tubules and colocalize with Candida (9), are 
unable to confer protection beyond the first 24 hours after infec-
tion (10); in fact, neutrophils within tubules mediate immunopa-
thology in the late phase of infection (10, 40). Furthermore, the 
localization of Candida outside renal tubules during only the first 
hours after infection highlights the role of tissue-resident kidney 
macrophages as an innate “barrier” to the rapid spread of Candida 
from the renal interstitium into the tubules. Future studies using 
dynamic intravital imaging will be required to better define the in 
vivo interaction of tissue-resident macrophages with Candida in 
the infected kidney early after infection before inexorable fungal 
growth ensues within the renal collecting system.
The dysfunctional CX3CR1-M280 SNP, which has been associated 
with protection from cardiovascular disease (29) in agreement with 
protection against atherosclerosis in Cx3cr1–/– mice (41), provided 
a unique opportunity to extend our mouse findings to humans. 
Hence, consistent with our data in Cx3cr1–/– mice, we found that 
the CX3CR1-M280 allele is associated with an increased suscep-
tibility to candidemia and disseminated disease in patients of 
mixed European descent. The lack of such association in African-
American individuals may reflect race-specific differences in the 
pathogenesis of the infection or could be due to the small sample 
size. Because mortality of candidemic patients exceeds 30%–40% 
despite antifungal therapy, identification of genetic factors such as 
CX3CR1-M280 that may predispose to systemic candidiasis could 
lead to individualized risk stratification and antifungal prophylax-
is strategies in patients. Moreover, because the clinical outcome of 
systemic candidiasis varies substantially among patients with sim-
ilar clinical and microbiological risk factors, discovery of genetic 
factors such as CX3CR1-M280 that predispose to disseminated 
disease could result in individualized prognostication strategies 
and in identification of candidemic patients in which intensified 
diagnostic and therapeutic interventions may be warranted. Like 
any genetic association study, it is possible that the association 
reported here is due to population stratification or linkage with 
another as-yet-unknown SNP; thus, this finding requires valida-
tion in future cohort studies. However, the fact that Cx3cr1–/– mice 
have heightened susceptibility to systemic candidiasis suggests 
that the association is direct.
In conclusion, our study demonstrates that CX3CR1 is critical 
for innate host defense against the most common human fungal 
pathogen, acting by promoting macrophage survival and accumu-
lation in tissue, which is associated with early efficient contact of 
tissue-resident macrophages with the fungus and control of Can-
dida growth and immune evasion. In agreement, we identify the 
dysfunctional CX3CR1-M280 SNP as a potential novel factor for risk 
assessment and prognostication in systemic candidiasis in humans.
Methods
Mice. Female Cx3cr1+/+ WT and Cx3cr1–/– C57BL/6 mice, and CD45.1+ con-
genic B6.SJL mice were obtained from Taconic Farms. The Cx3cr1–/– mice 
were generated as previously described (41) and were backcrossed onto 
the C57BL/6 background for 10 generations. Female Cx3cr1+/+ WT and 
Cx3cr1gfp/gfp C57BL/6 mice were obtained from the Jackson Laboratories. 
The Cx3cr1gfp/gfp mice were generated as described previously (20) and were 
backcrossed onto the C57BL/6 background for 10 generations. Cx3cr1gfp/+ 
mice were obtained by crossing Cx3cr1gfp/gfp with Cx3cr1+/+ WT mice. Female 
Ccr2–/– C57BL/6 mice were obtained from the Jackson Laboratories and 
were backcrossed onto the C57BL/6 background for 9 generations. Mice 
were maintained under specific pathogen–free housing conditions and 
were used at 8 to 12 weeks of age unless otherwise stated.
Fungal strains and mouse model of systemic candidiasis. The Candida albicans 
strains SC5314, CAF2-1 (gifts of John Bennett, National Institute of Aller-
gy and Infectious Diseases [NIAID]), and UC820 were used in the present 
study. SC5314-EGFP, a prototrophic derivative of SC5314, was previously 
described (42). CAF2-1-dTomato, a derivative of the prototrophic CAF2 
strain (43), was created by transformation with a custom synthetic con-
struct containing the PENO1 promoter, a C. albicans codon–optimized dTo-
mato gene, the TTEF terminator, and a nourseothricin resistance marker 
(synthesized by Genscript Inc.). Transformants were selected on 100 μg/ml 
nourseothricin and screened both for correct integration at the ENO1 locus 
by PCR and for high fluorescence by flow cytometry.
Candida was grown in yeast extract, peptone, and dextrose medium contain-
ing penicillin and streptomycin (Mediatech Inc.) in a shaking incubator at 
30°C. Cells were centrifuged, washed in PBS, counted using a hemocytom-
eter, and injected into mice via the lateral tail vein. 105 Candida yeast cells were 
injected per mouse unless stated otherwise.
Table 1
Association of the mutant CX3CR1-M280 allele with susceptibility to systemic candidiasis in subjects of mixed European descent  
from 2 cohorts (Netherlands and USA)
 No systemic candidiasis Systemic candidiasis P value OR (95% CI)
Netherlands subjects  167 37 0.0033 2.90 (1.40–6.04)
 CC 111 (66.5%) 15 (40.5%)  
 CT + TT 56 (33.5%) 22 (59.5%)  
USA subjects 156 166 0.0379 1.62 (1.03–2.54)
 CC 105 (67.3%) 93 (56%)  
 CT + TT 51 (32.7%) 73 (44%)  
Combined (Netherlands + USA) 323 203 0.0017 1.78 (1.24–2.55)
 CC 216 (66.9%) 108 (53.2%)  
 CT + TT 107 (33.1%) 95 (46.8%)  
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Fungal burden determination. Infected mice were euthanized on days 3, 6, 
and 9 after infection to determine the tissue fungal burden in the kidney, 
brain, liver, and spleen. The organs were aseptically removed, weighed, 
homogenized using the Omni Tissue Homogenizer (Omni International), 
serially diluted, and plated on yeast extract, peptone, and dextrose agar 
plates containing penicillin and streptomycin. CFUs were determined after 
48 hours of incubation at 37°C and results were expressed as CFUs/g of 
tissue. From 2 to 3 independent experiments were performed using a com-
bined total of 22 to 23 Cx3cr1+/+ and 19 to 22 Cx3cr1–/– mice per time-point.
Mouse histology and immunohistochemistry. Mice were euthanized on days 3, 
6, and 9 after infection and the kidney, brain, spleen, and liver were removed, 
fixed with 10% formalin, and embedded in paraffin. Tissue sections were 
prepared for H&E, PAS staining, or immunohistochemistry (IHC). For IHC 
staining, tissue sections were placed on poly-l-lysine–coated glass slides, 
deparaffinized in xylene, and rehydrated in a graded series of alcohol. After 
antigen retrieval for 20 minutes at 85°C, endogenous peroxidase blocking 
was carried out in alcohol solution containing 0.3% hydrogen peroxide for 
10 minutes at room temperature. The slides were then incubated in 5% 
BSA (Sigma-Aldrich) solution for 20 minutes to block nonspecific protein 
binding and washed with Tris-buffered saline containing 0.05% Tween 20 
(TBST). Then the primary goat polyclonal anti-rat Cx3cl1 (1:20; AF537; 
R&D Systems) or normal goat IgG isotype control (1:20; AB-108-C; R&D 
Systems) was added in 1% BSA and slides were incubated overnight at room 
temperature. The slides were washed twice with TBST, and 
the secondary biotinylated anti-goat IgG antibody (1:500; 
BA-5000; Vector) was added. The slides were incubated for 
30 minutes at room temperature and, following a TBST 
wash, detection of immunoreaction was achieved using 
the streptavidin–horseradish peroxidase (SA–horseradish 
peroxidase) system (1:400; Dako) containing SA-peroxi-
dase complex after 30 minutes incubation at room tem-
perature. Color was developed with 3,3′-diaminobenzidine 
(Sigma-Aldrich) and hydrogen peroxide (Sigma-Aldrich), 
and slides were subsequently counterstained with hema-
toxylin, dehydrated in graded ethanol, and mounted with 
Permount (Fisher Scientific). At least 2 different sections 
of each organ per time point were tested per experiment 
in 3 independent experiments using a combined total of 8 
Cx3cr1+/+ and 8 Cx3cr1–/– mice.
Confocal microscopy. Confocal microscopy was performed 
on freshly excised, unfixed kidneys from Cx3cr1gfp/+ and 
Cx3cr1gfp/gfp mice at 2 hours, day 1, and day 6 after intra-
venous Candida challenge. The animals were euthanized 
by carbon dioxide asphyxiation, and both kidneys were 
rapidly excised, sliced longitudinally, and placed in PBS 
solution on ice. The sliced tissue was then placed into a 
custom-made dish fitted with 40 mm round glass coverslip no. 1.5. Imag-
ing was carried out within 30 minutes after excision to ensure preserved 
morphology of the fresh tissue using an Olympus IX81 inverted microscope 
equipped with a Fluoview 1000 confocal scanning head (Olympus America). 
GFP was excited with a 488-nm laser, whereas dTomato was excited with 
a 561-nm laser. The emission was collected using appropriate filter sets. 
Cx3cr1+/+ animals and animals injected with Candida not expressing dTo-
mato were used as controls to determine the proper acquisition settings 
for GFP-expressing cells and dTomato-expressing fungus, respectively. The 
images were acquired using the following objectives: ×2, ×10, and UPLSA-
PO ×60 numerical aperture (NA) 1.2 water immersion objective (Olympus 
America). The focal plane for lower magnification objectives was set at 
approximately 10 μm from the surface of the tissue, and then single plane 
snapshots were acquired. Some of the images using the ×60 objective were 
acquired as 43-slice Z-stacks. Pixel width was set to 414 nm, and the Z-step 
was set to 0.79 μm to achieve minimal overlap between the adjacent slices. 
Images were prepared in Imaris Bitplant Scientific software (version 7.5.2) 
by taking snapshots of maximal intensity projections of the Z-stacks.
To compare the interaction of dTomato-Candida with Cx3cr1gfp/+ versus 
Cx3cr1gfp/gfp kidney mononuclear phagocytes in vivo, both kidneys from 
Cx3cr1gfp/+ and Cx3cr1gfp/gfp mice infected 2 hours prior to euthanization 
were processed as mentioned above. The percentage of Candida in contact 
with mononuclear phagocytes was quantified by evaluating 11–28 ran-
Table 2
Factors significantly associated with susceptibility to systemic candidiasis in subjects of mixed European descent  
(n = 322, USA subjects) in multivariate analysis
 Model A OR (95% CI) Model B OR (95% CI)
Solid organ transplant 10.93 (2.43–49.15) 12.03 (2.71–53.44)
Receipt of total parenteral nutrition  8.72 (3.21–23.70) 8.79 (3.24–23.82)
Neutropenia (ANC < 500 cells/mm3) 4.19 (1.49–11.76) 3.59 (1.30–9.94)
Liver disease 3.34 (1.37–8.13) 3.95 (1.66–9.43)
ICU admission within past 14 days 1.81 (1.06–3.10) Not included
CX3CR1-M280 CT + TT 1.60 (0.94–2.72) 1.80 (1.07–3.01)
 
Table 3
Association of the mutant CX3CR1-M280 allele with development of disseminated 
candidiasis after candidemia in subjects of mixed European descent (n = 166)
Variable Disseminated infection
 Univariate analysis Multivariate analysisA
 P value OR (95% CI)
Female 0.58 
Solid organ transplant <0.01 3.65 (1.48–8.99)
Active malignancy 0.41 
Chemotherapy within 3 months 0.79 
Neutropenia (ANC <500 cells/mm3) 0.38B 
Surgery within past 30 days 0.16 
Receipt of total parenteral nutrition 0.48 
Dialysis dependent 1.00B 
Acute renal failure 0.50 
Immunocompromised state 0.23 
ICU admission within past 14 days 0.89 
Liver disease 0.49 
CX3CR1-M280 CT + TT 0.01 2.83 (1.30–6.45)
AOnly those factors that were significant on multivariate analysis. BFisher’s exact test.
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domly selected dTomato-Candida structures on the surface of each kidney 
and determining whether they were in contact with GFP-expressing mono-
nuclear phagocytes. Three independent experiments were performed using 
a combined total of 3 Cx3cr1gfp/+ and 3 Cx3cr1gfp/gfp mice per time point.
Determination of serum blood urea nitrogen and creatinine. Blood urea nitro-
gen (BUN) and creatinine concentrations were measured in the serum of 
Cx3cr1+/+ and Cx3cr1–/– mice at day 9 after infection as markers of renal 
function. Blood was collected by cardiac puncture and stored at –80°C 
until analysis of BUN and creatinine at the NIH Clinical Chemistry Labo-
ratory. Two independent experiments were performed using a combined 
total of 8–10 Cx3cr1+/+ and 8–10 Cx3cr1–/– mice.
Gene expression analysis by real-time quantitative PCR. Control uninfected 
and Candida-infected Cx3cr1+/+ and Cx3cr1–/– mice were euthanized on 
days 3, 6, and 9 after infection (n = 4–5 mice per time point), and mRNA 
was extracted from the kidney using Trizol (Invitrogen) and the RNeasy 
kit (QIAGEN) according to the manufacturer’s instructions. cDNA was 
generated using the qScript cDNA SuperMix kit (Quanta BioSciences) 
with oligodT and random primers, and quantitative PCR (qPCR) was 
performed by SYBR Green (PerfeCTa SYBR Green FastMix ROX; Quanta 
BioSciences) or TaqMan detection (PerfeCTa qPCR FastMix ROX; Quan-
ta BioSciences) with the 7900HT Fast Real-Time PCR System (Applied 
Biosystems) in a total reaction volume of 22 μl using 2 μl cDNA, 11 μl 
2× SYBR Green or TaqMan PCR Master mix, and 1.1 μl of forward primer/ 
1.1 μl of reverse primer (SYBR Green) or 1.1 μl primer–probe mix (Taq-
Man). All qPCR assays were performed in duplicate and the relative gene 
expression of each molecule compared with uninfected mice was deter-
mined after normalization with GAPDH transcript levels using the ΔΔCT 
method, displayed as mRNA fold change. The primers using SYBR Green 
detection were designed from GenBank sequences using software Prim-
er3 (http://frodo.wi.mit.edu/primer3/) and purchased from Invitrogen 
(sequences shown in Supplemental Table 5), whereas TaqMan prim-
ers/probes were predesigned by Applied Biosystems. Two independent 
experiments were performed using a combined total of 8–10 Cx3cr1+/+ 
and 8–10 Cx3cr1–/– mice per time point.
Chemokine protein quantification. Kidneys from Cx3cr1+/+ and Cx3cr1–/– 
mice were harvested before infection and at days 3, 6, and 9 after infec-
tion and were homogenized with an Omni Tissue Homogenizer into 
PBS with 0.5% Tween 20 (Bio-Rad) and a protease inhibitor cocktail 
(11873580001; Roche Applied Science) and centrifuged at 15,682 g for 
10 minutes at 4°C. The supernatants were clarified, aliquoted, and fro-
zen at –80°C until use. Mouse Cxcl1 and Cxcl2 were quantified using a 
Luminex Magnetic bead array Milliplex MAP Kit (MCYTOMAG-70K; 
Millipore). One experiment was performed using a total of 4 Cx3cr1+/+ 
and 4 Cx3cr1–/– mice per time point.
Single-cell suspension from mouse kidney. Mice were euthanized before infec-
tion and at days 1, 3, 6, and 9 after infection (n = 3–5 mice/time point). 
Mice were anesthetized using ketamine/xylazine and perfused with 10 ml 
of normal saline before kidney harvesting. Single-cell suspensions from 
kidney were prepared using previously described methods (9). In brief, kid-
neys were finely minced and digested at 37°C in digestion solution (RPMI 
1640 with 20 mM HEPES [Mediatech] without serum) containing liberase 
TL (05401020001; Roche) and grade II DNAse I (10104159001; Roche) for 
20 minutes with shaking. Digested tissue was passed through a 70-μm fil-
ter and washed; the remaining red cells were lysed with ACK lysis buffer 
(Lonza). Then,the cells were passed through a 40-μm filter, washed, and 
suspended in 40% Percoll (GE Healthcare). The suspension was overlaid on 
70% Percoll and centrifuged at 836 g for 30 minutes at room temperature. 
The leukocytes and nonhematopoietic cells at the interphase were isolated, 
washed 3 times in FACS buffer (PBS plus 0.5% BSA plus 0.01% NaN3), sus-
pended in PBS, and passed though a 40-μm filter.
Flow cytometry. The single-cell suspensions were first stained with a 
LIVE/DEAD fluorescent dye (L-23105; Invitrogen) for 10 minutes (1:500) 
in PBS at 4°C and then incubated with rat anti-mouse CD16/32 (2.4G2; 
BD Biosciences) for 10 minutes (1:100) in FACS buffer at 4°C to block Fc 
receptors. For staining of surface antigens, cells were incubated with flu-
orochrome-conjugated (FITC, PE, PE-Cy7, allophycocyanin [APC], APC-
Cy7, APC-eFluor 780, Alexa Fluor 700, eFluor 450, eFluor 605 NC, or Per-
CP-Cy5.5) antibodies against mouse CD45 (Ly-5), CD45.1 (A20), CD45.2 
(clone 104) (eBioscience); Ly6C (AL-21), Ly6G (1A8) (BD Biosciences); 
F4/80 (BM8), CD11b (M1/70), MHC II (M5/114.15.2), CD11c (N418), 
CD103 (2E7), TCR-β (H57-597), CD3e (145-2C11), CD4 (GK1.5), CD8 (53-
6.7), CD19 (1D3), NK1.1 (PK136), CD117/c-Kit (2B8), TLR2/CD282 (6C2) 
(eBioscience); dectin-1 (GE2) (AbD Serotec); CD29/Integrin-β1 (HMb1-1), 
CD31/PECAM-1 (clone 390), CD102/ICAM-2 (3C4), and CD324/E-cad-
herin (DECMA-1) (eBioscience). After 3 washes with FACS buffer, stained 
cells were analyzed on a 5-laser LSRII (BD Biosciences), and the data were 
analyzed using FACS Diva (BD Biosciences) and FlowJo software (Tree-
star). Only single cells were analyzed, and cell numbers were quantified 
using PE-conjugated fluorescent counting beads (Spherotech).
FACS analysis of macrophages and neutrophils for annexin V and 7-AAD 
expression. To determine whether Cx3cr1 deficiency affects macrophage 
and neutrophil survival before and after Candida infection, we performed 
FACS analysis on kidney leukocytes from Cx3cr1+/+ and Cx3cr1–/– mice on 
days 0, 1, 3, 6, and 9 after infection. Cells were initially incubated for 10 
minutes with rat anti-mouse CD16/32 and then stained for 30 minutes 
with the combination of fluorochrome-conjugated Ly6G (BD Biosciences), 
CD45, MHCII, F4/80, CD11b, CD3, CD19, and NK1.1 (eBioscience). Then 
the cells were washed twice with PBS, suspended in 1× annexin V binding 
buffer (BD Biosciences), and incubated for 15 minutes with 5 μl each of 
FITC-conjugated annexin V and 7-AAD according to the manufacturer’s 
instructions (BD Biosciences). The cells were washed and FACS was per-
formed on a 5-laser LSRII. Two independent experiments were performed 
using a total of 6 to 8 Cx3cr1+/+ and 6 to 8 Cx3cr1–/– mice per time point.
FACS analysis of macrophages for Ki-67 expression. To determine whether 
Cx3cr1 deficiency affects in situ proliferation of macrophages in the kid-
ney before and after Candida infection, we performed FACS analysis on 
kidney macrophages from Cx3cr1+/+ and Cx3cr1–/– mice on days 0, 3, 6, 
and 9 after infection. Cells were initially incubated for 10 minutes with 
a LIVE/DEAD fluorescent dye, followed by a 10-minute incubation with 
rat anti-mouse CD16/32 and were then stained for 30 minutes with the 
combination of fluorochrome-conjugated CD45, MHCII, F4/80, CD11b, 
CD3, CD19, NK1.1, and Ly6G (eBioscience and BD Biosciences). Then the 
cells were washed twice with PBS, fixed, and permeabilized for 20 minutes 
with the BD Cytofix/Cytoperm solution (BD Biosciences) and incubated 
for 30 minutes with PE-conjugated mouse monoclonal anti-human Ki-67 
(51-36525X, clone B56; BD Biosciences) or PE-conjugated mouse IgG1 
(51-35405X, clone MOPC-21; BD Biosciences) in BD Perm/Wash buf-
fer according to the manufacturer’s instructions (BD Biosciences). After 
intracellular staining with Ki-67 or isotype control, the cells were washed 
and FACS was performed on a 5-laser LSRII. Two independent experi-
ments were performed using a combined total of 6 to 8 Cx3cr1+/+ and 6 to 
8 Cx3cr1–/– mice per time point.
FACS analysis of macrophages for pAKT and cleaved caspase-3 expression. To 
determine whether Cx3cr1 deficiency affects Akt phosphorylation and 
caspase-3 cleavage in kidney-resident macrophages, we performed FACS 
analysis on kidney macrophages from uninfected Cx3cr1+/+ and Cx3cr1–/– 
mice. Cells were initially incubated for 10 minutes with a LIVE/DEAD 
fluorescent dye, followed by a 10-minute incubation with rat anti-mouse 
CD16/32, and were then stained for 30 minutes with the combination of 
fluorochrome-conjugated CD45, MHCII, F4/80, and CD11b (eBioscience).
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CD45–CD102+ endothelial cells (purity, >90%) at steady state, and from 
kidney CD45–E-cadherin+ tubular cells (purity, >86%) at steady state using 
Trizol per the manufacturer’s protocol. cDNA was generated, and qPCR 
was performed for Cx3cl1 as described above. Relative gene expression was 
determined after normalization with GAPDH transcript levels using the 
ΔΔCT method and displayed as gene amplicons. Two to three independent 
experiments were performed using a combined total of 4 to 6 Cx3cr1+/+ mice.
Western blot analysis on sorted kidney macrophages. MHCIIhiF4/80hiCD11b+ 
macrophages were FACS sorted (purity, >96%) from Cx3cr1+/+ and Cx3cr1–/– 
kidneys at day 6 after infection for Western blot analysis of cleaved cas-
pase-3 and phosphorylated Akt. Sorted cells were washed once with ice-
cold PBS and lysed in buffer containing 50 mM HEPES, 50 mM NaCl, 
10% glycerol, 0.5% Nonidet P-40, 2 mM EDTA, and a Protease and 
Phosphatase Inhibitor Cocktail (Thermo Scientific). Cell lysates were cen-
trifuged at 13,200 g for 10 minutes at 4°C, and equal protein amounts 
from the supernatant were resuspended in SDS loading buffer with 5% 
β-mercaptoethanol for downstream Western blot analysis. Proteins were 
analyzed by SDS-PAGE and transferred to Immobilon P membranes, as 
previously described (44). Blocking was performed by incubating the mem-
branes with TBST containing 5% nonfat dry milk. Membranes were then 
incubated with rabbit monoclonal antibodies against cleaved caspase-3 
(9661 and 9664; Cell Signaling Technology) or phospho-Akt (Thr308) 
(2965; Cell Signaling Technology), and polyclonal antibody against 
β-actin (4967; Cell Signaling Technology) for 2 hours at room temperature 
under continuous agitation, washed 3 times with TBST, and incubated 
with horseradish peroxidase–conjugated anti-rabbit secondary antibody 
(Southern Biotech) for 1 hour at room temperature. Membranes were sub-
sequently washed, and detection of immunoreactive bands was performed 
using the SuperSignal West Fempto Maximum Sensitivity Substrate 
chemiluminescence (ECL) detection kit according to the manufacturer’s 
instructions (Pierce Biotechnology). The protein levels that corresponded 
to the immunoreactive bands were quantified using ImagePC image analy-
sis software (Scion Corp.). Two independent experiments were performed 
using a combined total of 16 Cx3cr1+/+ and 16 Cx3cr1–/– kidneys, which were 
pooled in 4 groups, each consisting of 4 kidneys from 2 mice.
Generation of BM chimeras. For BM cell transfers, femurs and tibias from 
donor 6- to 8-week-old Cx3cr1+/+ (CD45.1+) and Cx3cr1–/– (CD45.2+) mice were 
removed aseptically and BM was flushed using cold PBS supplemented with 2 
mM EDTA. Six- to eight-week-old recipient Cx3cr1+/+ (CD45.1+) and Cx3cr1–/– 
(CD45.2+) mice were irradiated with 9 Gy and were reconstituted 6 hours 
after irradiation with 5 × 106 Cx3cr1+/+ (WT→WT and WT→Cx3cr1–/– mice) 
or Cx3cr1–/– (Cx3cr1–/–→Cx3cr1–/– and Cx3cr1–/–→WT mice) cells by lateral 
tail-vein injection. Mice were given trimethoprim/sulfamethoxazole in the 
drinking water for the first 4 weeks of reconstitution before being switched 
to antibiotic-free water. Chimeras were infected with Candida 10 weeks after 
transplantation. Prior to infection, we confirmed that mice reconstituted 
with congenic BM stem cells had achieved a satisfactory level of chimerism 
by assessing the number of CD45.1+ (Cx3cr1+/+) and CD45.2+ (Cx3cr1–/–) leu-
kocytes in the blood and kidney, using flow cytometry. In the blood, the pro-
portion of donor-derived monocytes, neutrophils, and B cells exceeded 95%, 
whereas that of T cells exceeded 85% (Supplemental Figure 2). In the kidney, 
the proportion of donor-derived macrophages exceeded 90% in Cx3cr1–/–→WT 
mice and 96% in WT→Cx3cr1–/– mice (Supplemental Figure 2). Two indepen-
dent experiments were performed using a combined total of 15 WT→WT, 15 
Cx3cr1–/–→Cx3cr1–/–, 25 WT→Cx3cr1–/–, and 25 Cx3cr1–/–→WT mice.
Isolation and adoptive transfer of BM monocytes. 3 × 106 Fms-like tyrosine 
kinase 3 ligand–expressing (FLT3L-expressing) B16 cells (gift of Brian Kel-
sall, NIAID) were injected subcutaneously in Cx3cr1gfp/+ and Cx3cr1gfp/gfp 
donor mice 12–14 days before monocyte isolation to increase their total BM 
monocyte numbers (45). BM was then flushed from the tibias and femurs of 
For cleaved caspase-3 intracellular staining, the cells were washed twice 
with PBS, fixed, and permeabilized for 20 minutes with the BD Cytofix/
Cytoperm solution (BD Biosciences), and incubated for 30 minutes with or 
without PE-conjugated rabbit anti-cleaved caspase-3 (550821; BD Biosci-
ences) in BD Perm/Wash buffer according to the manufacturer’s instruc-
tions (BD Biosciences). The cells were then washed and FACS was per-
formed on a 5-laser LSRII. Three independent experiments were performed 
using a combined total of 9 Cx3cr1+/+ and 9 Cx3cr1–/– mice.
For pAKT intracellular staining, the cells were washed twice with PBS, 
fixed with 4% formaldehyde for 10 minutes at room temperature, and per-
mealized with an overnight incubation with ice-cold 90% methanol. The 
cells were then washed and incubated for 30 minutes with PE-conjugated 
mouse monoclonal anti-AKT (pT308) (558275, clone J1-223.371; BD Bio-
sciences) or PE-conjugated mouse IgG1, k isotype control (556620, clone 
MOPC-21; BD Biosciences) in FACS buffer. The cells were then washed and 
FACS was performed on a 5-laser LSRII. Two independent experiments 
were performed using a combined total of 6 Cx3cr1+/+ and 6 Cx3cr1–/– mice.
FACS analysis of hematopoietic and nonhematopoietic cells for Ccr2 and Cx3cr1 
expression. To determine the expression of Ccr2 and Cx3cr1 on hematopoietic 
and nonhematopoietic cells in the kidney, we performed FACS analysis on 
kidney cells from Cx3cr1+/+ and Cx3cr1gfp/+ mice on days 0, 1, 3, and 6 after 
infection. Single-cell suspensions were prepared as described above, and cells 
were incubated for 10 minutes with a LIVE/DEAD fluorescent dye, followed 
by staining with rat anti-mouse CD16/32 for 10 minutes. Then the cells were 
stained for 30 minutes with a combination of fluorochrome-conjugated 
antibodies for labeling CD45+ hematopoietic (MHCII, F4/80, CD11c, Ly6C, 
Ly6G, CD11b, CD103, CD3, CD19, NK1.1; eBioscience and BD Biosciences) 
and CD45– nonhematopoietic cells (CD29, CD31, CD102, CD324; eBiosci-
ence) and PE-conjugated rat monoclonal anti-mouse Ccr2 (FAB5986P, clone 
643854; R&D Systems) or PE-conjugated rat IgG2B (IC013P, clone 141945; 
R&D Systems). The cells were then washed and FACS was performed on a 
5-laser LSRII. Two independent experiments were performed using a com-
bined total of 6 Cx3cr1+/+ and 6 Cx3cr1gfp/+ mice per time point.
Isolation of kidney monocytes, macrophages, and DCs for TEM. MHCII–
F4/80intCD11b+ monocytes, MHCIIhiF4/80hiCD11b+ macrophages, and 
MHCIIhiF4/80loCD11chi dendritic cells were FACS sorted from Candida-
infected Cx3cr1+/+ mice at day 6 after infection for TEM analysis. Single-cell 
suspensions from kidneys were prepared as described above and, follow-
ing Fc blockade, cells were stained with FITC-conjugated CD45, eFluor 
450–conjugated MHCII, PE-Cy7–conjugated F4/80, PerCP-Cy5.5–conju-
gated CD3, CD19 and NK1.1, APC-conjugated CD11c, APC-eFluor 780–
conjugated CD11b (eBioscience), Alexa Fluor 700–conjugated Ly6C, and 
PerCP-Cy5.5–conjugated Ly6G (BD Biosciences). The 3 myeloid cell popu-
lations were sorted using a FACSAria instrument (BD Biosciences). Purity 
of sorted monocytes, macrophages, and dendritic cells was greater than 
96%. FACS-sorted monocytes, macrophages, and dendritic cells were then 
centrifuged and cell pellets were fixed overnight at 4°C with 2.5% glutaral-
dehyde/4% paraformaldehyde in 0.1 M sodium cacodylate buffer (15960; 
Electron Microscopy Sciences) and then post-fixed for 30 minutes with 
0.5% osmium tetroxide/0.8% potassium ferricyanide, 1 hour with 1% tan-
nic acid, and overnight with 1% uranyl acetate at 4°C. Samples were dehy-
drated with a graded ethanol series and embedded in Spurr’s resin. Thin 
sections were cut with an RMC MT-7000 Ultramicrotome (Ventana) and 
stained with 1% uranyl acetate and Reynold’s lead citrate before viewing at 
80 kV on a transmission electron microscope (H-7500; Hitachi). Digital 
images were acquired with a Hamamatsu XR-100 bottom-mount charge-
coupled device system (Advanced Microscopy Techniques).
Gene expression of Cx3cl1 on sorted kidney cells. Cx3cr1+/+ mice were used to 
extract mRNA from FACS-sorted kidney MHCIIhiF4/80hiCD11b+ macro-
phages (purity, >92%) at steady state and day 6 after infection, from kidney 
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FITC-labeled zymosan particles [Z2841; Invitrogen]) at a ratio of 25 yeast 
cells (or 25 zymosan particles) per macrophage as previously described 
(46). The yeast cells (or zymosan particles) were allowed to bind to BMMs 
for 30 minutes on ice, and unbound yeast cells (or zymosan particles) were 
washed 3 times with RPMI 1640 supplemented with 10% FBS, 2 mM L-glu-
tamine, and 1% penicillin/streptomycin. Then the BMMs were lysed with 
3% Triton X-100 (Sigma-Aldrich) and transferred to black 96-well plates 
(Greiner Bio-One Inc.). Fluorescence was measured using a fluorescent 
plate reader with excitation wavelength of 484 nm (or 490 nm for zymosan 
particles) and emission wavelength of 510 nm (or 514 nm for zymosan 
particles). From 2 to 3 independent experiments were performed using a 
combined total of 6 to 9 Cx3cr1+/+ and 6 to 9 Cx3cr1–/– mice.
Candida phagocytosis by BMMs. To determine whether Cx3cr1 deficiency 
affects the capacity of macrophages to internalize Candida, 106 Cx3cr1+/+ 
or Cx3cr1–/– BMMs were incubated for 30 minutes at 37°C with opsonized 
EGFP-Candida yeast cells at a Candida/BMM ratio of 1:1 or 5:1. After wash-
ing, BMMs were incubated with a biotinylated anti–C. albicans antibody 
(ab53892; Abcam) for 30 minutes at 4°C followed by a 20-minute incu-
bation with APC-conjugated SA (eBioscience). The percentage of Candida 
phagocytosis by BMMs was then determined using FACS by initially gating 
on FITC+ macrophages and then by determining the percentage of FITC+ 
macrophages that had internalized Candida (FITC+APC–) versus those that 
had Candida bound on the cell surface (FITC+APC+). Four independent 
experiments were performed using a combined total of 12 Cx3cr1+/+ and 
12 Cx3cr1–/– mice.
Candida killing by kidney-resident macrophages. To determine whether 
kidney-resident macrophages have Candida-killing capacity and to assess 
whether Cx3cr1 deficiency affects the capacity of these cells to kill Candida, 
we used the alamarBlue-based fluorescence assay, as previously described 
(28). In brief, 5 × 104 FACS-sorted kidney MHCIIhiF4/80hiCD11b+ mac-
rophages (purity, >97%) from uninfected Cx3cr1+/+ or Cx3cr1–/– mice were 
incubated in flat-bottom 96-well plates (Corning Inc.) with opsonized 
Candida yeast cells at a macrophage/Candida ratio of 2:1 in duplicate for 
3 hours at 37°C in a 5% CO2 incubator. Then the wells were treated with 
0.02% Triton X-100 in water for 5 minutes to lyse macrophages, washed 
twice with PBS, and incubated with alamarBlue (Invitrogen) for 18 hours 
at 37°C. Fluorescence was measured using a POLARstar OPTIMA plate 
reader (BMG LABTECH). Killing was calculated by comparing the fluo-
rescence of Candida incubated with macrophages with that of Candida 
incubated without macrophages. Three independent experiments were 
performed using a combined total of 6 Cx3cr1+/+ and 6 Cx3cr1–/– mice.
Human subjects. Patients were enrolled between January 2003 and January 
2009 at the Duke University Hospital (DUMC) and Radboud University 
Nijmegen Medical Center (RUNMC) (Supplemental Table 2). The clinical 
characteristics of the Candida-infected and noninfected control patients are 
summarized in Supplemental Table 3.
CX3CR1 genotype and susceptibility to systemic candidiasis. To be included in 
the analysis of susceptibility to systemic candidiasis, infected subjects from 
both DUMC and RUNMC must have had 1 or more positive blood cul-
tures for a Candida species while hospitalized at the participating center; 
infected subjects were enrolled consecutively. Noninfected controls from 
DUMC must have been hospitalized with no history or evidence of candi-
demia/systemic candidiasis or any other systemic fungal infection. None 
of the control patients were on antifungal therapy/prophylaxis. Although 
it was impracticable to match controls on specific risk factors, noninfected 
control individuals were recruited consecutively from the same hospital 
wards/services as Candida-infected patients during the study period, with 
a similar balance of medical, surgical, and oncology patients in Candida-
infected and noninfected control groups. Subjects were excluded from 
the study if insufficient volume of blood or clinical data were available to 
donor mice as described above. After red blood cell lysis using ACK lysis buffer 
(Lonza), CD115+ cells were enriched using the AutoMACS automatic mag-
netic cell-sorting system on an AutoMACS separator (Miltenyi Biotec) using 
a biotinylated CD115 antibody (AFS98; eBioscience) followed by anti-biotin 
microbeads (130-090-485; Miltenyi Biotec) according to the manufacturer’s 
instructions. CD115-enriched cells were then stained for Alexa Fluor 700–con-
jugated Ly6C (AL-21), APC-eFluor 780–conjugated CD11b (M1/70), SA-PE, 
and a mixture of APC-conjugated lineage antibodies (TCR-β [H57-597], CD4 
[GK1.5], CD8 [53-6.7], CD19 [1D3], NK1.1 [PK136], CD11c [N418], CD117/
c-Kit [2B8] and Ly6G [1A8]). Monocytes were sorted as Lin–CD115biotin/
SA+GFP(Cx3cr1)+Ly6ChiCD11b+ cells using a FACSAria (BD Biosciences) (45). 
Monocyte purity after sorting was greater than 98%. Monocytes were resus-
pended in sterile PBS at a final concentration of 20 × 106 cells/ml, and a total 
of 4 × 106 (200 μl) Cx3cr1gfp/+ or Cx3cr1gfp/gfp monocytes were injected intrave-
nously per animal in Cx3cr1+/+ Candida-infected mice on day 3 after infection.
To determine the role of Cx3cr1 on trafficking of monocytes from 
the blood into the kidney, mice were euthanized 12 hours after mono-
cyte transfer, and to determine the role of Cx3cr1 on differentiation of 
monocytes into kidney macrophages and cell persistence into the kidney, 
mice were euthanized 3 days after monocyte transfer. The kidneys were 
harvested and single-cell suspensions were prepared as described above. 
After LIVE/DEAD staining and Fc blockade, leukocytes were stained with 
eFluor 605 NC–conjugated CD45, eFluor 450-conjugated MHCII, PE-Cy7–
conjugated F4/80, APC-conjugated CD11c, Alexa Fluor 700–conjugated 
Ly6C, and APC-eFluor 780–conjugated CD11b. Monocyte migration from 
the blood into the kidney was calculated based on the number of GFP+ 
Cx3cr1gfp/+ versus Cx3cr1gfp/gfp monocytes detected in the kidney at 12 hours 
after transfer. Two independent experiments were performed using a com-
bined total of 14 Cx3cr1+/+ mice, 8 injected with Cx3cr1gfp/+ monocytes and 6 
injected with Cx3cr1gfp/gfp monocytes. Monocyte differentiation into kidney 
macrophages was calculated based on the percentage of GFP+ Cx3cr1gfp/+ 
versus Cx3cr1gfp/gfp cells that had become MHCIIhiF4/80hiCD11b+ macro-
phages 3 days after transfer. Cell persistence in the kidney was calculated 
based on the number of GFP+ Cx3cr1gfp/+ versus Cx3cr1gfp/gfp cells detected 
in the kidney at 3 days after transfer. Two independent experiments were 
performed using a combined total of 12 Cx3cr1+/+ mice, 6 each injected 
with Cx3cr1gfp/+ or Cx3cr1gfp/gfp monocytes.
Generation of BMMs and FACS analysis for Cx3cr1 expression. BMMs were 
generated by culturing BM cells obtained as described above from Cx3cr1+/+ 
and Cx3cr1–/– mice in RPMI 1640 supplemented with 10% FBS, 2 mM 
L-glutamine (Mediatech), 20 mM HEPES, 1% penicillin/streptomycin and 
40 ng/ml M-CSF (Peprotech Inc.) for 5 to 7 days, at which time point more 
than 95% of cells were viable and expressed F4/80 and CD11b (data not 
shown). BMMs were Cx3cr1+ as determined by FACS using a combined 
total of 6 Cx3cr1+/+ and 6 Cx3cr1gfp/+ mice in 2 independent experiments 
(data not shown).
Expression of dectin-1 and TLR2 on BMMs. 106 Cx3cr1+/+ or Cx3cr1–/– BMMs 
were incubated for 10 minutes with a LIVE/DEAD fluorescent dye, fol-
lowed by a 10-minute incubation with rat anti-mouse CD16/32 to block 
Fc receptors. Then the cells were stained for 30 minutes with FITC-conju-
gated rat monoclonal anti-mouse dectin-1 (2A11; AbD Serotec), PE-conju-
gated rat monoclonal anti-mouse TLR2/CD282 (6C2; eBioscience), or rat 
IgG2B conjugated with FITC or PE (eB149/10H5; eBioscience). The cells 
were then washed and FACS was performed on a 5-laser LSRII. Two inde-
pendent experiments were performed using a combined total of 4 Cx3cr1+/+ 
and 5 Cx3cr1–/– mice.
Binding of Candida and zymosan by BMMs. To determine whether Cx3cr1 
deficiency affects the capacity of macrophages to bind Candida or zymosan, 
2.5 × 105 Cx3cr1+/+ or Cx3cr1–/– BMMs were plated in 24-well tissue culture 
plates (Corning Inc.) and were incubated with EGFP-Candida yeast cells (or 
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tal Table 4). Univariate correlations were performed by use of the Pearson 
correlation coefficient or Fisher’s exact test as appropriate. Differences 
in genotypic frequencies for the CX3CR1-M280 allele were examined for 
significance using the Pearson χ2 test or Fisher’s exact test. Standard sum-
mary statistics (OR and 95% CI) were reported for these tests of associa-
tion. Baseline demographic and clinical categorical variables in the case 
and control groups were compared by χ2 analysis or Fisher’s exact test (as 
appropriate), and variables with P < 0.1 were analyzed as confounders of 
the CX3CR1-M280 SNP using logistic regression. SAS software version 9.2 
(SAS Corporation) was used for all analyses.
Within the infected DUMC cohort, allelic frequencies were further 
assessed in association with 4 prespecified clinical outcomes: (a) dissemi-
nated disease, (b) persistent fungemia, (c) all-cause mortality at 14 days, 
and (d) all-cause mortality at 30 days. Variables with P < 0.1 were further 
assessed in a multivariable logistic regression model using backward 
elimination. Variables with P < 0.05 were retained in the final predictive 
model. ORs and 95% CIs were reported for variables that remained sig-
nificant in the final multivariable model.
Study approval. All mice were maintained at an American Association 
for the Accreditation of Laboratory Animal Care–accredited animal 
facility at the NIAID and housed in accordance with the procedures 
outlined in the Guide for the Care and Use of Laboratory Animals 
under the auspices of a protocol approved by the Animal Care and Use 
Committee of the NIAID.
The study patients were enrolled after informed consent (or waiver as 
approved by the Institutional Review Board) at DUMC and RUNMC. The 
study was approved by the Institutional Review Boards at each study center 
and was performed in accordance with the Declaration of Helsinki.
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allow for analysis. In addition, allogeneic hematopoietic stem cell trans-
plant patients were excluded. Immunocompromised status was defined as 
any of the following conditions: neutropenia (absolute neutrophil count 
<500/mm3), CD4+ lymphopenia (absolute CD4 count <250/mm3 associ-
ated with or without HIV), chronic steroid use or receipt of immunosup-
pressive chemotherapy/immunosuppressant medications within 30 days 
prior to baseline, diabetes mellitus, and end-stage renal disease requiring 
hemodialysis. Acute renal failure was defined based on clinical diagnosis, 
including doubling of serum creatinine and/or requirement for acute 
dialysis (intermittent hemodialysis or continuous veno-venous hemofiltra-
tion dialysis). Noninfected controls from RUNMC were healthy volunteers 
from the Netherlands enrolled between 2009 and 2011 without history of 
infection or underlying chronic disease. None of the control patients from 
RUNMC were on antifungal therapy/prophylaxis. Intergroup comparisons 
between the 2 groups of noninfected subjects and between the 2 groups of 
Candida-infected subjects (at DUMC and RUNMC) were performed regard-
ing similarity in genetic distribution of the studied CX3CR1 SNP prior to 
further statistical analysis of Candida-infected versus noninfected subjects.
CX3CR1 genotype and association with clinical outcomes after systemic 
candidiasis. Due to the lack of detailed clinical data on the Dutch candidemia 
patients recruited at RUNMC, the correlations of the CX3CR1 genetic data 
with clinical outcome were performed only for the patients from DUMC 
(n = 244). Infected subjects at DUMC were followed prospectively following 
diagnosis of candidemia to determine clinical outcome. Mortality data, 
including date of death, was ascertained from hospital records and/or the 
National Social Security Death Index. Disseminated infection was defined 
as the presence of Candida species at sterile body sites outside the blood-
stream with the exception of urine. The most frequent manifestations of 
disseminated infection were abdominal abscess/peritonitis (55%), hepato-
splenic candidiasis (13%), and endocarditis/endovascular infection (11%). 
Persistent fungemia was defined as 5 days or more of persistently positive 
Candida blood cultures.
CX3CR1-M280 genotyping. A 50-μl PCR reaction was performed to geno-
type this site using 200 ng of genomic DNA isolated from whole blood 
using standard procedures and 15 pmoles of each of the following primers: 
5′-AGAATCATCCAGACGCTGTTTTCC-3′ and 5′-CACAGGACAGCCAG-
GCATTTCC-3′. Other conditions were as follows: 2.0 mM MgCl2, 175 μM 
each of dNTP, 1.5 U Taq polymerase, and 1X buffer (Life Technologies). 
Amplification reactions were performed using 35 cycles of 95°C, 69°C, and 
72°C for 30 seconds each, preceded by a single cycle of 95°C for 3 minutes 
and followed by a single cycle of 72°C for 10 minutes. This produced an 
amplicon of 311 bp. In order to type the alleles at codon 280, 5 μl of the 
resulting PCR reaction mix was digested with 1.5 U of Bst4CI (New Eng-
land BioLabs) in a 20-μl reaction incubated overnight at 65°C according 
to the manufacturer’s instructions. This resulted in 107- and 204-bp frag-
ments when a C was present at nucleotide 839 of the open reading frame, 
while the amplicon remained uncut if a T was present. The genotype was 
determined by electrophoresis on a 2% agarose gel stained with Gelstar 
(FMC Bioproducts) according to the manufacturer’s instructions.
Statistics. The mouse experimental data were analyzed using the 2-tailed 
unpaired t-test or the Mann-Whitney test where appropriate with Prism 6.0 
software (GraphPad Software) and are presented as the mean ± SEM. The 
cutoff for statistical significance was defined as P < 0.05.
For the analysis of the impact of the CX3CR1 genotype on susceptibility 
to candidemia, statistical comparisons of frequencies were made between 
Candida-infected versus noninfected subjects using the χ2 test. Data were 
analyzed for individuals of mixed European descent separately from Afri-
can-Americans, as allelic frequencies were expected to differ between these 
2 populations; indeed, examination of race-stratified genotype frequencies 
for the tested SNP confirmed this expectation (Table 1 and Supplemen-
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